COVID-19
Conditions
Interventions
None listed
Sponsors
The Japanese Respiratory Society
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who were hospitalized for COVID-19 and were discharged by December 31, 2021 Patients of moderate or higher Patients who have consent
Exclusion criteria
Exclusion criteria: Patients under the age of 20 Cases judged by the attending physician to be ineligible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Actual condition of sequelae such as deterioration of lung function after COVID-19 1.Changes in pulmonary function tests (FVC, DLCO, TLC, etc.). 2.Lung volume pred Total lung capacity ratio in Chest CT scan 3. Subjective symptoms (shortness of breath: mMRC, olfaction, dysgeusia, malaise, headache, fever, chronic fatigue syndrome diagnostic criteria, Pittsburgh sleep questionnaire, etc.) 4. Changes in chest CT (HRCT) findings | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Search for factors (including biomarkers) that predict lung dysfunction and other sequelae 2.The actual condition survey of rehabilitation for sequlae of COVID-19 Reality | — |
Countries
Japan
Contacts
Public ContactKazufumi Takamatsu
Kochi Medical school, Kochi University Department of Respiratory and Allergy Medicine,
Outcome results
None listed